How Is The Market Valuing Cannabis Vs. Tobacco, Alcohol And Pharmaceutical Sectors?
Faced with challenging industry dynamics, economic headwinds, and unresolved doubts regarding any federal regulatory reform, investors have become less willing to pay for rosy EBITDA growth projections.
